Cargando…

Risk factors of severe COVID-19 in people with multiple sclerosis : A systematic review and meta-analysis

OBJECTIVES: To gather, synthesize, and meta-analyze data regarding the risk factors associated with a severe course of COVID-19 among patients with multiple sclerosis (pwMS). METHODS: MEDLINE, Embase, Scopus, and WoS were searched in May 2021. Briefly, the eligibility criteria included: 1) studies a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Etemadifar, M., Nouri, H., Maracy, M.R., Akhavan Sigari, A., Salari, M., Blanco, Y., Sepúlveda, M., Zabalza, A., Mahdavi, S., Baratian, M., Sedaghat, N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Masson SAS. 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566345/ https://www.ncbi.nlm.nih.gov/pubmed/34836608 http://dx.doi.org/10.1016/j.neurol.2021.10.003

Ejemplares similares

Self-Reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis
por: Etemadifar, Masoud, et al.
Publicado: (2022)

Complete horizontal gaze palsy due to bilateral paramedian pontine reticular formation involvement as a presentation of multiple sclerosis: a case report
por: Akhavan Sigari, Amirhossein, et al.
Publicado: (2019)

Outcome of COVID-19 infection in multiple sclerosis patients receiving disease-modifying therapies
por: Etemadifar, Masoud, et al.
Publicado: (2021)

Successful seroconversion following mild COVID-19 contraction in a double-vaccinated B-cell-depleted person with multiple sclerosis: A hint towards booster efficacy?
por: Etemadifar, Masoud, et al.
Publicado: (2021)

Detection of anti-NMDA receptor antibodies following BBIBP-CorV COVID-19 vaccination in a rituximab-treated person with multiple sclerosis presenting with manifestations of an acute relapse
por: Etemadifar, Masoud, et al.
Publicado: (2022)

Recognition of the Kind of Stress Coping in Patients of Multiple Sclerosis
por: Hajhashemi, A., et al.
Publicado: (2010)

Association of COVID-19 with Disability Progression and Disease Exacerbation in People with Relapsing-Remitting Multiple Sclerosis: Evidence from a Year-Long Observational Study
por: Sedaghat, Nahad, et al.
Publicado: (2022)

COVID-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight with No Bystander Effect?
por: Etemadifar, Masoud, et al.
Publicado: (2021)

Effect of multiple sclerosis disease-modifying therapies on the real-world effectiveness of two doses of BBIBP-CorV (Sinopharm) vaccine
por: Etemadifar, Masoud, et al.
Publicado: (2023)

Myasthenia gravis and coronavirus disease 2019: A report from Iran
por: Etemadifar, Masoud, et al.
Publicado: (2021)

WITHDRAWN: Incidence and mortality of COVID-19 in Iranian multiple sclerosis patients treated with disease-modifying therapies
por: Etemadifar, M., et al.
Publicado: (2020)

Does COVID-19 increase the long-term relapsing-remitting multiple sclerosis clinical activity? A cohort study
por: Etemadifar, Masoud, et al.
Publicado: (2022)

Multiple sclerosis in sarcoidosis patients: Two case reports
por: Etemadifar, Masoud, et al.
Publicado: (2022)

SARS-CoV-2 serology among people with multiple sclerosis on disease-modifying therapies after BBIBP-CorV (Sinopharm) inactivated virus vaccination: Same story, different vaccine
por: Etemadifar, Masoud, et al.
Publicado: (2022)

Rituximab induced cytokine release syndrome in an MS patient: A case report
por: Etemadifar, Masoud, et al.
Publicado: (2021)

Third COVID-19 vaccine dose for people with multiple sclerosis who did not seroconvert following two doses of BBIBP-CorV (Sinopharm) inactivated vaccine: A pilot study on safety and immunogenicity
por: Sedaghat, Nahad, et al.
Publicado: (2023)

Movement Disorders Associated with COVID-19
por: Salari, Mehri, et al.
Publicado: (2021)

Aftercare services for patients with severe mental disorder: A randomized controlled trial
por: Barekatain, Majid, et al.
Publicado: (2014)

Association of urodynamic findings in new onset multiple sclerosis with subsequent occurrence of urinary symptoms and acute episode of disease in females
por: Tadayyon, Farhad, et al.
Publicado: (2012)

Post-COVID-19 acute disseminated encephalomyelitis: Case report and review of the literature
por: Etemadifar, Masoud, et al.
Publicado: (2022)

Interferon beta-1b-induced thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) in a patient treated for multiple sclerosis: A case report
por: Etemadifar, Masoud, et al.
Publicado: (2018)

Epidemiological and clinical features of pediatric-onset multiple sclerosis: A population-based study in Isfahan, Iran, between 1997-2020
por: Etemadifar, Masoud, et al.
Publicado: (2021)

Effect of Fingolimod on Platelet Count Among Multiple Sclerosis Patients
por: Farrokhi, Mehrdad, et al.
Publicado: (2015)

Dalfampridine: Review of its Efficacy in Improving Gait in Patients with Multiple Sclerosis
por: Sahraian, M.A., et al.
Publicado: (2011)

Effect of disease duration on personality type in multiple sclerosis patients and healthy individual
por: Vesal, Sahar, et al.
Publicado: (2016)

Conversion from Radiologically Isolated Syndrome to Multiple Sclerosis
por: Etemadifar, Masoud, et al.
Publicado: (2014)

Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions
por: Cohen, Jeffrey A, et al.
Publicado: (2022)

The role of information system in multiple sclerosis management
por: Ajami, Sima, et al.
Publicado: (2014)

Multiple sclerosis in Isfahan, Iran: Past, Present and Future
por: Etemadifar, Masoud, et al.
Publicado: (2012)

Cooccurrence of Chorea-Acanthocytosis and Mesial Temporal Sclerosis: A Possible Role of Caudate Nucleus
por: Salari, Mehri, et al.
Publicado: (2017)

Myelin status is associated with change in functional mobility following slope walking in people with multiple sclerosis
por: King, EM, et al.
Publicado: (2018)

Systemic Sclerosis, Reversible Cerebral Vasoconstriction Syndrome, and NeuroMyelitis Optica in a Patient
por: Etemadifar, Masoud, et al.
Publicado: (2022)

A comparative study on iMed(©) and European database for multiple sclerosis to propose a common language of multiple sclerosis data elements
por: Ajami, Sima, et al.
Publicado: (2014)

Identifying falls remotely in people with multiple sclerosis
por: Block, Valerie J., et al.
Publicado: (2021)

Fatigue, depression, and physical impairment in multiple sclerosis
por: Azimian, Mojtaba, et al.
Publicado: (2014)

Barriers to quality of life in patients with multiple sclerosis: a qualitative study
por: Hosseini, Zahra, et al.
Publicado: (2022)

Cervical Spinal Canal Stenosis and Central Disc Herniation C3/4 in a Man with Primary Complaint of Thigh Pain
por: Akhavan-Sigari, R., et al.
Publicado: (2013)

Does levetircetam decrease of the rubral tremor in patients with multiple sclerosis
por: Chitsaz, Ahmad, et al.
Publicado: (2013)

Combination therapy with mitoxantrone and plasma exchange in aggressive relapsing remitting multiple sclerosis: A preliminary clinical study
por: Tabrizi, Nasim, et al.
Publicado: (2012)

Effects of whole body vibration on hormonal & functional indices in patients with multiple sclerosis
por: Ebrahimi, Ali, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jri50h5257khpf1a2j445obi4g